Frontiers of stem cell transplantation monitoring: Capturing graft dynamics through routine longitudinal chimerism analysis

Israel Medical Association Journal

Volumn 9, Issue 3, 2007, Pages 159-162

  Kristt, Don ^a   Stein, Jerry ^a   Klein, Tirza ^a  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

Author keywords

Bone marrow transplantation; Chimerism testing; ChimerTrack ; Lineage specific chlmerism analysis; Stem cell transplantation

Indexed keywords

DNA; HLA ANTIGEN; IMMUNOSUPPRESSIVE AGENT;

ALLOGENEIC STEM CELL TRANSPLANTATION; CELL LINEAGE; CELL SPECIFICITY; CELL SUBPOPULATION; CHIMERA; COMPUTER PROGRAM; CONFERENCE PAPER; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOMODULATION; INDIVIDUALIZATION; LABORATORY TEST; LONGITUDINAL STUDY; MEDICAL DECISION MAKING; NONMYELOABLATIVE CONDITIONING; PATIENT CARE; PATIENT MONITORING; POLYMERASE CHAIN REACTION; PROGNOSIS; QUANTITATIVE ANALYSIS; RELIABILITY; SENSITIVITY AND SPECIFICITY; TANDEM REPEAT;

GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; MONITORING, PHYSIOLOGIC; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SOFTWARE; STEM CELL TRANSPLANTATION; TRANSPLANTATION CHIMERA; TRANSPLANTATION CONDITIONING;

EID: 33947506734     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (20)

1. McCann SR, Lawler M. Monitoring outcome: MRD, chimaerism and relapse. In Haematopoietic Stem Cell Transplantation. Berlin: EBMT, 2004:196-212.
2. Khan F, Agarwal A, Agrawal S. Significance of chimerism hematopoietic stem cell transplantation: new variation on an old theme. Bone Marrow Transplant 2004;34:1-12.
3. Senitzer D, Gaidulis L. Short tandem repeat analysis of engraftment in allogeneic stem cell transplantation ASHI Quart 2001;25:49-54.
4. Kristt D, Stein I, Yaniv I, Klein T. Assessing quantitative chimerism longitudinally: technical considerations, clinical applications and routine feasibility. Bone Marrow Transplant 2007;39:255-68.
5. Kristt D, Israell M, Narinski R, Stein J, Yaniv I, Klein T. Hematopoietic chimerism monitoring based on STRs: quantitative platform perfomance on sequential samples J Biontol Tech 2005;16: 392-403.
6. Kristt D, Stein J, Yaniv I, Klein T. Interactive ChimerTrack software facilitates computation, visual displays and long-term tracking of chimeric status based on STRs. Leukemia 2004:18:909-11.
7. Kristt D, Klein T. Reliability of quantitative chimerism results: assessment of sample performance using novel parameters. Leukemia 2006;20:1169-72.
8. Kristt D, Narinski R, Or H, Stein J, Yaniv I, Klein T. Differential levels of chimeric tolerance in a single patient: how much change in quantitative chimerism values is enough for clinical significance? 32nd Annual Meeting of the European Group for Blood and Marrow Transplantation, Hamburg. 2006, Abstract R1157.
9. Lion T, Muller-Bérat N. Debate Round-Table: chimerism testing after allogeneic stem cell transplantation importance of timing and optimal technique for testing in different clinical-biological situations. Leukemia 2003:17:612-33.
10. Baron F, Baker JE, Strob R, et al. Kinetics of engraftment inpatients with hematologic malignancies given allogeneic hematopoietic all transplantation after non-myeloablative conditioning. Blood 2004;104:2254-62.
11. Lee K-H, Lee J-H. Choi S-J, et al. Monthly prospective analysis of hematopoietic chimerism after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2003;32:423-31.
12. Bader P, Beck J, Frey A, et al. Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT. Bone Marrow Transplant 1998;21:487-95.
13. Thlede C, Bornhauser M. Oelschlagel U, et al. Sequential monitoring of chimerism and detection of minimal residual disease after allogeneic blood stem cell transplantation BHSCT using multiplex PCR amplification of short tandem repeat-markers. Leukemia 2001;15:293-302.
14. Dubovsky I, Daxberger H, Fritsch G, et al. Kinetics of chimerism during the early post-transplant period in pediatric patients with malignant and non-malignant hematologic disorders. Implications for timely detection of engraftment, graft failure and rejection. Leukemia 1999;13:2060-9.
15. Rapanotti MC, Arcese W, Buffollno S, et al. Sequential molecular monitoring of chimerism in chronic myeloid leukemia patients receiving donor lymphocytes transfusions for relapse after bone marrow transplantatlon. Bone Marrow Transplant 1997;19:703-7.
16. Gardiner N, Lawler M, O'Riodan JM, Duggan C, De-Arce M. McCann SR. Monitoring of lineage-specific chimaerism allows early prediction of response following donor lymphocyte infusions for relapse chronic myeloid leukaemia. Bone Marrow Transplant 1998;21:7117-19
17. Butler JM. Commonly used short tandem repeat markers. In: Forensic DNA Typing. San Diego: Academic Press, 231:53-79.
18. Thiede C: Diagnostic chimerism analysis after allogeneic stem cell transplantation: new methods and markers. Am J Pharmacogenom 2004;4:177-87.
19. Antin JH, Childs R. Filipovich AH, et al. Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendation from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant 2001;7:473-85.
20. Perez-Simon JA, Caballero D, Diez-Campelo M, et al. Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation. Leukemia 2002;16:1423-31